Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis

NCT03139136 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: MBS2320
DRUG: Placebo

Sponsor

Modern Biosciences Ltd